BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19054570)

  • 1. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
    Tohen M; Sutton VK; Calabrese JR; Sachs GS; Bowden CL
    J Affect Disord; 2009 Jul; 116(1-2):43-50. PubMed ID: 19054570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
    Tohen M; Wang WV; Leboyer M; Jen KY
    J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
    Keck PE; Calabrese JR; McQuade RD; Carson WH; Carlson BX; Rollin LM; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2006 Apr; 67(4):626-37. PubMed ID: 16669728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
    Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A; Rendell JM; Geddes J
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004367. PubMed ID: 19160237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode.
    Berwaerts J; Melkote R; Nuamah I; Lim P
    J Affect Disord; 2012 May; 138(3):247-58. PubMed ID: 22377512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP; Ahl J; Meyers AL; Kaiser CJ; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
    Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
    J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.